|
|
I-MED Pharma innovates and distributes medical, surgical and veterinary eye care products. Our mission is simple yet challenging: perfecting sight. To achieve this we continually conduct research, develop and source the most effective and advanced solutions to eye disorders like cataracts, corneal transplants, dry eye, and glaucoma.
|

The OASIS Iris Expander is a temporary implant to assist the surgeon with mechanical dilation of a small pupil that is refractory to pharmacological dilation. It is constructed of polypropylene material and uses a disposable injector.
The Iris Expander provides stable mydriasis during cataract surgery with no trauma to the iris tissue and no need for additional paracenteses. The capsulorrhexis, hydrodissection, phacoemulsifica-tion, and injection of the IOL may occur with the device in place. At the conclusion of the procedure, the surgeon removes the Iris Expander from the eye.
Read more: Oasis Iris Expander

by Donald Tan, F.R.C.Ophth.
Several different inserter devices have become available to help the surgeon during implantation of the donor lenticule during DSAEK/DSEK. However, despite their use for over 2 years, there are very few published clinical studies demonstrating the outcomes of their use. One of the few inserters that has been used clinically that is both FDA and CE approved and with published clinical outcomes is the Tan EndoGlide (Angiotech, Reading, Pa.). The device is a single-use delivery system for simplified insertion of DSAEK donor tissue, which minimizes endothelial cell damage, with reported endothelial cell loss in the region of 15% at 6 months post-op. Two versions of the EndoGlide are now available: the EndoGlide Classic for normal thickness donors and the EndoGlide Ultrathin (UT) for ultrathin DSAEK.
To read more please visit the Eyeworld article by Dr. Tan
|
|
![]() |
Recently announced by OSN, a European Journal of Ophthalmology article claims that biomechanical changes induced by corneal collagen cross-linking in keratoconic corneas correlated with insignificant astigmatic correction, according to a study.
"Cross-linking is able to induce a corneal astigmatic change, but it is variable, not predictable, and insufficient to provide an effective astigmatic correction," the study authors said.
To read the abstract click here. |
| See how Intacs® can help your keratoconus patients |
NeurOptics, the worldwide leader in pupillometry, today announced the availability of the new VIP-200 Variable Pupillometer for the measurement of pupil size under varying light conditions to enhance opportunities for successful outcomes for refractive surgery and premium intraocular lens candidates. Using infrared imaging technology, the VIP-200 measures the pupil 30 times per second over a two-second period at scotopic, low mesopic and high mesopic light levels and provides the average pupil diameter and standard deviation with accuracy exceeding 0.1 millimeter. Pupil size measurement during a pre-operative evaluation is crucial for today's refractive surgeons when screening candidates for LASIK, and is particularly helpful for optimizing the premium IOL selection for the patient based upon the patient's stated preferences about the level of vision he or she values most (e.g., distance, intermediate or near), occupation, lifestyle, and frequency of nighttime driving. Pupil size affects vision with any IOL, but even more so for so-called "pupil-dependent IOLs".
Read more: NeurOptics Introduces First Hand-held Variable Light Condition Pupillometer